English | Español
Jamie Barrand | Dec 5, 2015

'American Journal of Preventive Medicine' supplement discusses needs of cancer survivors
Jamie Barrand | Dec 5, 2015

Once-daily formulation of Belviq under review by FDA
Jamie Barrand | Dec 4, 2015

Enzi calls Obamacare 'unworkable, unaffordable'
Jamie Barrand | Dec 4, 2015

CDC projects to educate public about PrEP as HIV prevention therapy
Jamie Barrand | Dec 4, 2015

U.S. Subcommittee on Health hearing to discuss six proposed bills
Kerry Goff | Dec 3, 2015

PIPC chief: 'Quality of life' often what patients want most from health care
Jamie Barrand | Dec 3, 2015

FDA approves new drug application for hepatitis C therapy
Jamie Barrand | Dec 3, 2015

Boehringer Ingelheim, MD Anderson Cancer Center partner to develop pancreatic cancer therapies

Trending
+ Pharmaceuticals
Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'
+ Marketing
Patient Daily | Sep 17, 2025

Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'